"Goserelin Acetate"^^ . "40224"^^ . "ZoladexBRNCI" . _:vb677322 . _:vb677325 . _:vb677323 . . "Goserelin_Acetate"^^ . "C1417"^^ . "D-Ser(bu(t))(6)azgly(10)-LHRH AcetateSNNCI" . _:vb677326 . . . "FDA"^^ . . "40224"^^ . _:vb677326 . "Goserelin Acetate"^^ . "Breast Carcinoma; Prostate Carcinoma; Endometriosis"^^ . . _:vb677324 . _:vb677325 . "GOSERELIN ACETATEPTFDA6YUU2PV0U8" . _:vb677326 . "C0700476"^^ . _:vb677324 . _:vb677322 . _:vb677323 . _:vb677323 . . _:vb677324 . "ZoladexSYDTPNSC0606864" . _:vb677325 . "ZDXABNCI" . _:vb677325 . "Pharmacologic Substance"^^ . . "Goserelin AcetatePTNCI" . "The acetate salt of a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH). Continuous, prolonged administration of goserelin in males results in inhibition of pituitary gonadotropin secretion, leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. (NCI04)NCI" . _:vb677326 . "6YUU2PV0U8"^^ . _:vb677323 . "65807-02-5"^^ . _:vb677322 . "Amino Acid, Peptide, or Protein"^^ . "606864"^^ . _:vb677324 . "C59H84N18O14.C2H4O2"^^ . _:vb677322 .